Bladder Cancer

Share this journal
Bladder-Cancer-Cover-FINAL-72dpi-rgb
ISSN print
2352-3727
ISSN online
2352-3735
Volume
3; 4 issues
Status
Last issue (3:2) published on 28 April 2017
Next issue
3:3 scheduled for July 2017
Back volumes
1-2
Website
www.bladdercancerjournal.com
Subject
Cancer Research, Urology
INSTITUTIONAL SUBSCRIPTION FOR 2017 (PRINT ONLY) €237 / US$288 Excluding VAT
Subscribe

Launch of New Website for Bladder Cancer Journal
Bladder Cancer is pleased to announce the launch of its new website www.bladdercancerjournal.com, to better serve the Bladder Cancer community.

Bladder Cancer Volume 2, Number 4 now Live
We are delighted to announce the publication of the sixth issue of Bladder Cancer (BLC), the first journal dedicated to the disease. Volume 2, Number 4 is freely available here.

Follow Bladder Cancer on Twitter and Facebook
We are pleased to inform you that Bladder Cancer now has its own Twitter account and Facebook page. Phillip Abbosh has agreed to act as Social Media Editor. He will be responsible for selecting and posting news of interest to the bladder cancer research community. Follow us on Twitter and Facebook!

Bladder Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the bladder and upper urinary tract. The journal publishes research reports, reviews, short communications, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that expedites our fundamental understanding and improves treatment of tumors of the bladder and upper urinary tract.

Editors-in-Chief

Seth P. Lerner, MD
Baylor College of Medicine
Scott Department of Urology
Houston, Texas, USA
Email: blc@iospress.com

Dan Theodorescu, MD, PhD
University of Colorado Cancer Center
NCI designated Comprehensive Cancer Center
Aurora, Colorado, USA
Email: blc@iospress.com

Associate Editors for Reviews

Georgios Gakis, MD, PhD
University Hospital Tübingen, Department of Urology, Tübingen, Germany

Matthew Galsky, MD
Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, USA

Associate Editors

Joaquim Bellmunt, MD, PhD
Harvard Medical School, Dana-Farber Cancer Institute, Boston, USA

Jason A. Efstathiou, MD, PhD
Massachusetts General Hospital, Harvard Medical School, Radiation Oncology, Boston, USA

Donna Hansel, MD, PhD
University of California, San Diego, Department of Pathology, San Diego, USA

Arndt Hartmann, MD
University Erlangen-Nürnberg, Institute of Pathology, Erlangen, Germany

Maha Hussain, MD
Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, USA

Anne Kiltie, MA, DM, DSc
University of Oxford, Department of Oncology, Oxford, United Kingdom

Cheryl Lee, MD
University of Michigan Hospitals, Cancer & Geriatrics Ctr, Ann Arbor, USA

Yair Lotan, MD
UT Southwestern Medical Center, Urology Clinic, Dallas, USA 

David McConkey, PhD
The University of Texas MD Anderson Cancer Center, Department of Urology, Houston, USA

Matt Milowsky, MD 
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, USA

Torben Ørntoft, MD 
Aarhus University Hospital, Department of Clinical Medicine, Aarhus, Denmark

Diane Zipursky Quale, BA, JD
Bladder Cancer Advocacy Network (BCAN), Bethesda, USA

Francisco X. Real, MD, PhD
CNIO (Spanish National Cancer Research Centre), Cancer Cell Biology Programme, Madrid, Spain

George Thalmann, MD 
University of Bern, Department of Urology, Bern, Switzerland

Xue-Ru Wu, MD
New York University (NYU), Department of Urology/Pathology, New York, USA

Alexandre R. Zlotta, MD, PhD
The Mount Sinai Hospital, Uro-Oncology, Toronto, Canada
Princess Margaret Cancer Centre, University Health Network, Department of Surgery, Toronto, Canada

Ellen Zwarthoff, PhD
Erasmus MC, Department of Pathology, Rotterdam, The Netherlands

Editors of Clinical Trials Corner

Piyush K. Agarwal, MD
National Cancer Institute, Urologic Oncology Branch, Bethesda, USA

Cora N. Sternberg, MD
San Camillo and Forlanini Hospitals, Medical Oncology, Roma, Italy

Editor of Paper Alert

Edward M. Messing, MD
University of Rochester Medical Center, Department of Urology, Rochester, USA

Social Media Editor

Phillip Abbosh, MD, PhD
Fox Chase Cancer Center at Temple University Hospital, Molecular Therapeutics, Philadelphia, USA

Editorial Board

Cory Abate-Shen, PhD
Columbia University Medical Center, Department of Urology, New York, USA

Hikmat Al-Ahmadie, MD
Memorial Sloan-Kettering Cancer Center, Department of Pathology, New York, USA

Matthew L. Albert, MD, PhD
Institut Pasteur, Department of Immunology, Paris, France

Ajjai Alva, MD
University of Michigan, Urologic Oncology Clinic, Ann Arbor, USA

Andrea B. Apolo, MD
National Cancer Institute, U.S. Department of Health and Human Services, Rockville, USA

Jessie Au, PharmD, PhD
Optimum Therapeutics, LLC, Columbus, USA

Marko Babjuk, MD
Motol University Hospital and 2nd Faculty of Medicine, Department of Urology, Prague, Czech Republic
 
Rick Bangs, MBA, PMP
Patient Advocate, Rochester Hills, USA

Trinity Bivalacqua, MD, PhD
Johns Hopkins Medicine, Department of Urology, Surgery and Oncology, Baltimore, USA

Peter Black, MD
University of British Columbia, Department of Urology, Vancouver, Canada

Bernard Bochner, MD 
Memorial Sloan-Kettering Cancer Center, Department of Urology, Surgery and Oncology, New York, USA

James Catto, MD, PhD
The University of Sheffield, Academic Urology Unit, Sheffield, United Kingdom

Karim Chamie, MD
University of California Los Angeles, Department of Urology, Los Angeles, USA

Keith Syson Chan, PhD
Baylor College of Medicine, Molecular & Cellular Biology/Scott Department of Urology, Houston, USA

Sam S. Chang, MD
Vanderbilt University Medical Center, Department of Urology, Nashville, USA

Liang Cheng, MD
Indiana University, Department of Pathology & Laboratory Medicine, Indianapolis, USA

Richard J. Cote, MD
University of Miami Miller School of Medicine, Department of Pathology, Miami, USA

Bogdan Czerniak, MD, PhD
University of Texas, Department of Pathology, Austin, USA

Garrett M. Dancik, PhD
Eastern Connecticut State University, Department of Computer Science, Willimantic, USA

Siamak Daneshmand, MD
University of Southern California, Department of Urology, Los Angeles, USA

Ian D. Davis, MD, PhD 
Monash University and Eastern Health, Department of Internal Medicine (General Medicine), Oncology, Urology, Melbourne, Australia

David J. DeGraff, PhD
Pennsylvania State University College of Medicine, Department of Pathology, Hershey, USA

Colin P.N. Dinney, MD
University of Texas MD Anderson Cancer Center, Department of Urology, Houston, USA

Lars Dyrskjøt, PhD
Aarhus University, Department of Molecular Medicine, Aarhus, Denmark 

Thomas Flaig, MD 
University of Colorado, Devision of Medical Oncology, Boulder, USA 

Scott M. Gilbert, MD
H. Lee Moffitt Cancer Center & Research Institute, Department of Urology, Tampa, USA

Peter J. Goebell, MD, PhD
Universitätsklinikum Erlangen, Department of Urology, Erlangen, Germany

John Gore, MD
University of Washington, Department of Urology, Seattle, USA

Noah Hahn, MD
Johns Hopkins University School of Medicine, Department of Oncology and Urology, Baltimore, USA

Richard Hautmann, MD
Universität Ulm, Department of Urology, Ulm, Germany

Jean Hoffman-Censits, MD
Thomas Jefferson University, Department of Medical Oncology, Philadelphia, USA

Andrew Hruszkewycz, MD, PhD
National Cancer Institute, NIH, Division of Cancer Treatment and Diagnosis, Bethesda, USA

Jer-Tsong Hsieh, PhD
UT Southwestern Medical Center, Department of Urology, Dallas, USA

Molly A. Ingersoll, PhD 
Institut Pasteur, Department of Immunology, Paris, France

Ashish M. Kamat, MD
University of Texas, Department of Urology, Austin, USA

Lawrence Karsh, MD
The Urology Center of Colorado, Department of Clinical Research, Denver, USA

Wassim Kassouf, MD
McGill University Health Center, Department of Urology, Montreal, Canada

Lambertus (Bart) Kiemeney, PhD 
Radboud University Medical Center, Department of Health Evidence, Nijmegen, The Netherlands

William Kim, MD
University of North Carolina, Department of Urology, Chapel Hill, USA

Deborah W. Knapp, DVM
Purdue University, Department of Veterinary Clinical Sciences, West Lafayette, USA

Margaret Knowles, PhD
Leeds Institute of Cancer & Pathology, Department of Experimental Oncology, Leeds, United Kingdom

Badrinath Konety, MD
University of Minnesota, Department of Urology, Minneapolis, USA

David J. Kwiatkowski, MD, PhD
Harvard Medical School, Department of Medicine, Boston, USA

Donald Lamm, MD
University of Arizona, Department of Surgery, Phoenix, USA

David Latini, PhD
Baylor College of Medicine, Department of Urology, Houston, USA

Nathan Lawrentschuk, MD, PhD
University of Melbourne, Department of Surgery, Victoria, Australia

Vinata Lokeshwar, PhD
University of Miami, Departments of Urology and Cell Biology, Miami, USA

Nuria Malats, MD
CNIO (Spanish National Cancer Research Centre), Human Cancer Genetics Programme, Madrid, Spain

Surena F. Matin, MD
University of Texas MD Anderson Cancer Center, Department of Urology, Division of Surgery, Houston, USA

Kazumasa Matsumoto, MD
Kitasato University, Department of Urology, Kanagawa, Japan 

James McKiernan, MD
Columbia University, Department of Urology, New York, USA

Reza Mehrazin, MD
The Mount Sinai Hospital, Department of Urology, New York, USA

Maxwell Meng, MD
University of California San Francisco, Department of Urology, San Francisco, USA

Timur Mitin, MD, PhD
Oregon Health and Science University, Portland, USA

Anirban P. Mitra, MD, PhD
University of Southern California, Institute of Urology, Los Angeles, USA

Ofer Nativ, MD
Bnai Zion Medical Center, Department of Urology, Haifa, Israel

Roman Nawroth, PhD
Technische Universität München, Urological Clinic, Munich, Germany

Matthew Nielsen, MD
UNC School of Medicine, Department of Urology, Chapel Hill, USA

Hiroyuki Nishiyama, MD, PhD
University of Tsukuba, Department of Urology, Tsukuba, Japan

Tim O'Brien, MD
Guy’s and St Thomas’, Urology Centre, London, United Kingdom

Michael A. O'Donnell, MD
University of Iowa Carver College of Medicine, Department of Urology, Iowa City, USA

Howard L. Parnes, MD
National Cancer Institute, NIH, Devision of Cancer Prevention, Bethesda, USA

Dan Petrylak, MD
Yale University, Department of Medical Oncology, New Haven, USA

Elizabeth R. Plimack, MD
Fox Chase Cancer Center, Department of Hematology/Oncology, Philadelphia, USA

Kamal Pohar, MD
Ohio State University, Department of Urology, Columbus, USA

Michael P. Porter, MD
University of Washington, Department of Urology, Seattle, USA

David Quinn, MD, PhD
University of Southern California, Department of Medicine, Los Angeles, USA

François Radvanyi, PhD
Institut Curie - UMR 144 - CNRS, Department of Subcellular Structure and Cellular Dynamics, Paris, France

Derek Raghavan, MD, PhD
Levine Cancer Institute, Charlotte, USA

Joan Palou Redorta, MD, PhD
Universitat Autónoma de Barcelona, Department of Surgery, Barcelona, Spain

Cyrill Rentsch, MD, PhD
University Hospital of Basel, Devision of Urology, Basel, Switzerland 

Bas W.G. van Rhijn, MD, PhD
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Surgical Oncology, Amsterdam, The Netherlands

Jonathan Rosenberg, MD
Memorial Sloan-Kettering Cancer Center, Department of Medical Oncology, New York, USA

Arthur I. Sagalowsky, MD
UT Southwestern, Department of Urology, Dallas, USA

Maria De Santis, MD
Cancer Research Centre, University of Warwick, Medical School, Department of Cancer Research, Coventry, United Kingdom

Marta Sánchez-Carbayo, PhD
University of the Basque Country, Department of Cancer Research, Bilbao, Spain

Bernd J. Schmitz-Dräger, MD, PhD
Schön Klinik Nürnberg Fürth, Department of Urology, Fürth, Germany

Mark P. Schoenberg, MD
The Albert Einstein College of Medicine & The Montefiore Medical Center, Department of Urology, New York, USA

Shahrokh F. Shariat, MD, PhD
Medical University Vienna, Department of Urology, Vienna, Austria

Padmanee Sharma, MD, PhD
The University of Texas MD Anderson Cancer Center, Department of Genitourinary Medical Oncology and Immunology, Houston, USA

Eila C. Skinner, MD 
Stanford University, Department of Urology, Stanford, USA

Angela B. Smith, MD
UNC-Chapel Hill School of Medicine, Department of Urology, Chapel Hill, USA

Carolyn Smith, PhD
Baylor College of Medicine, BCM-Michael Debakey Center, Houston, USA

Norm Smith, MD
University of Chicago, Section of Urology, Chicago, USA

Steven Christopher Smith, MD, PhD
Virginia Commonwealth University, School of Medicine, Richmond, USA

Walt Stadler, MD
University of Chicago, Section of Urology, Chicago, USA

Gary Steinberg, MD
University of Chicago, Section of Urology, Chicago, USA

Arnulf Stenzl, MD
Universitätsklinikum Tübingen, Department of Urology, Tübingen, Germany

Seth Strope, MD
Washington University, Devision of Urologic Surgery, St. Louis, USA

Robert Svatek, MD
UT Health Science Center San Antonio, Department of Urology, San Antonio, USA

Antonia Vlahou, PhD
Biomedical Research Foundation Academy of Athens, Department of Systems Biology, Athens, Greece

Nick Vogelzang, MD, FASCO 
Comprehensive Cancer Centers of Nevada, Department of Medical Oncology, Las Vegas, USA

J. Alfred Witjes, MD, PhD
Radboud University Nijmegen, Department of Urology, Nijmegen, The Netherlands

Statistical and Bioinformatics Editorial Board

Edward J. Bedrick, PhD
University of Colorado, Department of Biostatistics & Bioinformatics, Aurora, USA

Debashis Ghosh, PhD
University of Colorado, Department of Biostatistics and Informatics, Aurora, USA

Susan Groshen, PhD
University of Southern California, Department of Preventive Medicine, Los Angeles, USA

Michael C. Sachs, PhD
NIH, Biometric Research Program, Bethesda, USA

Richard Sylvester, ScD
EORTC, Department of Biostatistics and Informatics, Brussels, Belgium

Jeremy Taylor, PhD
University of Michigan, Department of Biostatistics, Ann Arbor, USA

Embase
Google Scholar

Bladder Cancer Funding Analyzer Launched on Bladder Cancer Website

16 Feb 2017 - Amsterdam, NL – Bladder Cancer (BLC) is proud to announce the launch of the Bladder Cancer Funding Analyzer (BCFA) on the BLC website. It is a free service that is part of a new suite of online features that have been designed to serve the needs of the bladder cancer research community....

New Analysis Shows Hexvix®/Cysview® Significantly Prolongs Time To Progression Of Bladder Cancer

29 Apr 2016 - Photocure ASA (OSE: PHO), is pleased to announce publication of a new analysis demonstrating that Blue Light Cystoscopy (BLC) with Hexvix/Cysview significantly prolonged time to disease progression and showed a trend in the reduction of the rate of progression in patients with non-muscle invasive bladder cancer (NMIBC). The data was published online in the April issue of the peer reviewed journal, Bladder Cancer. ...

Researchers Make Progress in Genomic Classification of Bladder Cancers

19 Feb 2016 - The ability to map the human genome has transformed how scientists and researchers classify various cancers. In the past, cancer cells were examined through a microscope and their appearance, often enhanced with dyes or other agents, was used to categorize the type of cancer. Now, it is possible to extract the DNA or RNA from these cells and establish a classification according to the type and quantity of mutations, active and inactive genes, and other molecular characteristics. An article in the current issue of Bladder Cancer reports the results of a consensus meeting of experts in the field and describes the recent efforts to classify bladder cancers....

IOS Press partners with Kudos

12 Jan 2016 - IOS Press is happy to announce its partnership with Kudos (www.growkudos.com), an award winning service that helps researchers maximize the impact and visibility of their research. Kudos allows authors to enrich their articles with lay metadata, add links to related materials and promote their articles through the Kudos system to a wider public. From their personal dashboard, authors can track how often their articles are viewed and shared through Kudos. The service will be available to authors of all IOS Press journal articles starting the first quarter of 2016. ...